270 related articles for article (PubMed ID: 25762721)
1. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
Russwurm C; Koesling D; Russwurm M
J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
Nishi A; Kuroiwa M; Miller DB; O'Callaghan JP; Bateup HS; Shuto T; Sotogaku N; Fukuda T; Heintz N; Greengard P; Snyder GL
J Neurosci; 2008 Oct; 28(42):10460-71. PubMed ID: 18923023
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; GiampĂ C; Sorge R; Biagioni S; Fusco FR; Sancesario G
J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
[TBL] [Abstract][Full Text] [Related]
5. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation.
Kotera J; Sasaki T; Kobayashi T; Fujishige K; Yamashita Y; Omori K
J Biol Chem; 2004 Feb; 279(6):4366-75. PubMed ID: 14604994
[TBL] [Abstract][Full Text] [Related]
7. Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease.
Kleiman RJ; Kimmel LH; Bove SE; Lanz TA; Harms JF; Romegialli A; Miller KS; Willis A; des Etages S; Kuhn M; Schmidt CJ
J Pharmacol Exp Ther; 2011 Jan; 336(1):64-76. PubMed ID: 20923867
[TBL] [Abstract][Full Text] [Related]
8. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
Strick CA; James LC; Fox CB; Seeger TF; Menniti FS; Schmidt CJ
Neuropharmacology; 2010 Feb; 58(2):444-51. PubMed ID: 19765598
[TBL] [Abstract][Full Text] [Related]
9. HPRT-deficiency dysregulates cAMP-PKA signaling and phosphodiesterase 10A expression: mechanistic insight and potential target for Lesch-Nyhan Disease?
Guibinga GH; Murray F; Barron N
PLoS One; 2013; 8(5):e63333. PubMed ID: 23691025
[TBL] [Abstract][Full Text] [Related]
10. Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia.
Charych EI; Jiang LX; Lo F; Sullivan K; Brandon NJ
J Neurosci; 2010 Jul; 30(27):9027-37. PubMed ID: 20610737
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodents.
Takakuwa M; Watanabe Y; Tanaka K; Ishii T; Kagaya K; Taniguchi H; Kotera J; Hashimoto K
Pharmacol Biochem Behav; 2019 Oct; 185():172757. PubMed ID: 31404565
[TBL] [Abstract][Full Text] [Related]
12. Regulation of neuronal PKA signaling through AKAP targeting dynamics.
Dell'Acqua ML; Smith KE; Gorski JA; Horne EA; Gibson ES; Gomez LL
Eur J Cell Biol; 2006 Jul; 85(7):627-33. PubMed ID: 16504338
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.
Menniti FS; Chappie TA; Humphrey JM; Schmidt CJ
Curr Opin Investig Drugs; 2007 Jan; 8(1):54-9. PubMed ID: 17263185
[TBL] [Abstract][Full Text] [Related]
14. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
Hebb AL; Robertson HA; Denovan-Wright EM
Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
[TBL] [Abstract][Full Text] [Related]
15. Regulation of A-kinase anchoring protein 79/150-cAMP-dependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin.
Gomez LL; Alam S; Smith KE; Horne E; Dell'Acqua ML
J Neurosci; 2002 Aug; 22(16):7027-44. PubMed ID: 12177200
[TBL] [Abstract][Full Text] [Related]
16. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2.
Sano H; Nagai Y; Miyakawa T; Shigemoto R; Yokoi M
J Neurochem; 2008 Apr; 105(2):546-56. PubMed ID: 18088367
[TBL] [Abstract][Full Text] [Related]
17. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
[TBL] [Abstract][Full Text] [Related]
18. The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey.
Smith SM; Uslaner JM; Cox CD; Huszar SL; Cannon CE; Vardigan JD; Eddins D; Toolan DM; Kandebo M; Yao L; Raheem IT; Schreier JD; Breslin MJ; Coleman PJ; Renger JJ
Neuropharmacology; 2013 Jan; 64():215-23. PubMed ID: 22750078
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 10A in the rat pineal gland: localization, daily and seasonal regulation of expression and influence on signal transduction.
Spiwoks-Becker I; Wolloscheck T; Rickes O; Kelleher DK; Rohleder N; Weyer V; Spessert R
Neuroendocrinology; 2011; 94(2):113-23. PubMed ID: 21474921
[TBL] [Abstract][Full Text] [Related]
20. PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
Ahmad R; Bourgeois S; Postnov A; Schmidt ME; Bormans G; Van Laere K; Vandenberghe W
Neurology; 2014 Jan; 82(3):279-81. PubMed ID: 24353339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]